Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05240638 · ClinicalTrials.gov registry record · NA

Lymph Drainage in Heart Failure

A NA study of Heart Failure, sponsored by Duke University.

Completed
Registry status
NA
Development phase
1
Enrollment target
1
Study location

NCT05240638 is a NA study of Heart Failure that has completed, run by Duke University. The registered enrollment target is 1 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05240638, a NA study of Heart Failure, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.

Conditions Studied

Interventions

  • DEVICE TD Drainage

Study Locations (1)

North Carolina

  • Marat Fudim - Durham

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2022-10-24
Est. Completion 2023-07-07
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05240638

The ClinicalTrials.gov registry entry for NCT05240638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which TD Drainage is the first listed.

NCT05240638 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05240638 about?

NCT05240638 is a clinical study titled "Lymph Drainage in Heart Failure". This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.

What is the current status of trial NCT05240638?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2022-10-24. Estimated completion is 2023-07-07.

What conditions does trial NCT05240638 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT05240638?

The interventions under investigation include: TD Drainage (DEVICE).

Who is sponsoring clinical trial NCT05240638?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05240638 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.